| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 03:03:14 UTC |
|---|
| Update Date | 2022-11-30 19:25:58 UTC |
|---|
| HMDB ID | HMDB0114906 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(18:1(11Z)/20:0) |
|---|
| Description | PA(18:1(11Z)/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(11Z)/20:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCC\C=C/CCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCCCC InChI=1S/C41H79O8P/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2/h14,16,39H,3-13,15,17-38H2,1-2H3,(H2,44,45,46)/b16-14-/t39-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-cis-Vaccenoyl-2-arachidoyl-sn-glycero-3-phosphate | HMDB | | 1-cis-Vaccenoyl-2-arachidoyl-sn-phosphatidic acid | HMDB | | PA(18:1/20:0) | HMDB | | PA(18:1N7/20:0) | HMDB | | PA(18:1W7/20:0) | HMDB | | PA(38:1) | HMDB | | Phosphatidic acid(18:1(11Z)/20:0) | HMDB | | Phosphatidic acid(18:1/20:0) | HMDB | | Phosphatidic acid(18:1n7/20:0) | HMDB | | Phosphatidic acid(18:1W7/20:0) | HMDB | | Phosphatidic acid(38:1) | HMDB | | Phosphatidate(18:1(11Z)/20:0) | HMDB | | Phosphatidate(18:1/20:0) | HMDB | | Phosphatidate(18:1N7/20:0) | HMDB | | Phosphatidate(18:1W7/20:0) | HMDB | | Phosphatidate(38:1) | HMDB | | [(2R)-2-(Icosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphonate | HMDB | | 1-cis-vaccenoyl-2-arachidoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-cis-vaccenoyl-2-arachidoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(18:1/20:0) | SMPDB, HMDB | | PA(18:1n7/20:0) | SMPDB, HMDB | | PA(18:1w7/20:0) | SMPDB, HMDB | | PA(38:1) | SMPDB, HMDB | | Phosphatidic acid(18:1(11Z)/20:0) | SMPDB, HMDB | | Phosphatidic acid(18:1/20:0) | SMPDB, HMDB | | Phosphatidic acid(18:1n7/20:0) | SMPDB, HMDB | | Phosphatidic acid(18:1w7/20:0) | SMPDB, HMDB | | Phosphatidic acid(38:1) | SMPDB, HMDB | | Phosphatidate(18:1(11Z)/20:0) | SMPDB, HMDB | | Phosphatidate(18:1/20:0) | SMPDB, HMDB | | Phosphatidate(18:1n7/20:0) | SMPDB, HMDB | | Phosphatidate(18:1w7/20:0) | SMPDB, HMDB | | PA(18:1(11Z)/20:0) | SMPDB |
|
|---|
| Chemical Formula | C41H79O8P |
|---|
| Average Molecular Weight | 731.049 |
|---|
| Monoisotopic Molecular Weight | 730.551256502 |
|---|
| IUPAC Name | [(2R)-2-(icosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-(icosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCC\C=C/CCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C41H79O8P/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2/h14,16,39H,3-13,15,17-38H2,1-2H3,(H2,44,45,46)/b16-14-/t39-/m1/s1 |
|---|
| InChI Key | KKQSRWGIVVMUSV-QRMPNUHKSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:1(11Z)) (PathBank: SMP0099660)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0074976)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:2(13Z,16Z)) (PathBank: SMP0074982)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/24:1(15Z)) (PathBank: SMP0074989)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086223)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:1(13Z)) (PathBank: SMP0090251)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099662)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/22:0) (PathBank: SMP0099663)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(11Z)/20:1(11Z)) (PathBank: SMP0099665)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099670)
- Phosphatidylcholine Biosynthesis PC(18:1(11Z)/20:0) (PathBank: SMP0063855)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0066225)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:1(11Z)) (PathBank: SMP0074973)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:0) (PathBank: SMP0074980)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0074986)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/24:0) (PathBank: SMP0074988)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:2(11Z,14Z)) (PathBank: SMP0090244)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0090253)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0090254)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:0) (PathBank: SMP0096121)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/22:1(13Z)) (PathBank: SMP0099664)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(11Z)/22:0) (PathBank: SMP0099668)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(11Z)/22:1(13Z)) (PathBank: SMP0099669)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099674)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0066226)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/20:0) (PathBank: SMP0071757)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099661)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099671)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/22:0/22:1(13Z)) (PathBank: SMP0099678)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0066223)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0066234)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:0) (PathBank: SMP0085196)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/22:0/22:0) (PathBank: SMP0099677)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/22:1(13Z)/22:1(13Z)) (PathBank: SMP0099679)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/18:1(11Z)) (PathBank: SMP0021726)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/18:1(9Z)) (PathBank: SMP0021727)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/18:2(9Z,12Z)) (PathBank: SMP0021732)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0021733)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0021738)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/20:0/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0021739)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:1(13Z)) (PathBank: SMP0081869)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(11Z)/20:1(13Z)) (PathBank: SMP0081873)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(13Z)/20:1(13Z)) (PathBank: SMP0081876)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(13Z)/22:0) (PathBank: SMP0081877)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(13Z)/22:1(13Z)) (PathBank: SMP0081878)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0085197)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0085198)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085201)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0085202)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0085203)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085204)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085205)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085206)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0085207)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085208)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0085209)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085210)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085213)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085215)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0085216)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099666)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099667)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0099672)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0099673)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0099675)
- Cardiolipin Biosynthesis CL(18:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0099676)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.54 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 36.9456 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.08 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5315.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 637.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 388.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 263.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1083.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1835.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1531.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 248.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3730.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1135.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2977.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1419.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 751.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 764.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 860.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(18:1(11Z)/20:0),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 5154.0 | Semi standard non polar | 33892256 | | PA(18:1(11Z)/20:0),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 4565.7 | Standard non polar | 33892256 | | PA(18:1(11Z)/20:0),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 6013.7 | Standard polar | 33892256 | | PA(18:1(11Z)/20:0),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 5111.0 | Semi standard non polar | 33892256 | | PA(18:1(11Z)/20:0),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 4549.9 | Standard non polar | 33892256 | | PA(18:1(11Z)/20:0),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 5252.3 | Standard polar | 33892256 | | PA(18:1(11Z)/20:0),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 5399.8 | Semi standard non polar | 33892256 | | PA(18:1(11Z)/20:0),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 4662.4 | Standard non polar | 33892256 | | PA(18:1(11Z)/20:0),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC | 5986.7 | Standard polar | 33892256 |
|
|---|